SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in ...
The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.
MedPage Today on MSN
GLP-1 agents tied to less risk of asthma exacerbations in teens with obesity
Adolescents with overweight or obesity and asthma had a lower risk of asthma exacerbations after starting a GLP-1 receptor ...
A trip to Grand Rapids took a terrifying turn for the Sokolowski family when their 9-year-old son, Leland, began gasping for air on the drive back home. The family quickly found themselves in an ...
The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...
A southwest Houston mother is accusing staff at her daughter's KIPP Mosaic Primary of failing to call 911 after the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results